PULM

Pulmatrix (PULM)

About Pulmatrix (PULM)

Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the development and discovery of novel inhaled therapeutics products. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov, and Robert S. Langer, Jr. in April 2003 and is headquartered in Framingham, MA.

Details

Daily high

$7.34

Daily low

$6.86

Price at open

$6.94

52 Week High

$8.44

52 Week Low

$1.55

Market cap

26.6M

Dividend yield

0.00%

Volume

41,315

Avg. volume

41,291

P/E ratio

-2.75

Pulmatrix News